JLE

Hépato-Gastro & Oncologie Digestive

MENU

Carcinome papillaire de la thyroïde de type cribriforme-morulaire et polypose adénomateuse familiale Volume 25, numéro 6, Juin 2018

  • [1] Lloyd RV, Osamura RY, Kloppel G, Rosai J. WHO classification of tumours : pathology and genetics of tumours of endocrine organs. 4th ed. Lyon : IRAC ; 2017.
  • [2] Rowland KJ, Moley JF. Hereditary thyroid cancer syndromes and genetic testing. J Surg Oncol 2015 ; 111 : 51-60.
  • [3] Lam A K-Y, Saremi N. Cribriform-morular variant of papillary thyroid carcinoma : a distinctive type of thyroid cancer. Endocrine-Related Cancer 2017 ; 24 : R109-R121.
  • [4] Tomoda C., Miyauchi A., Uruno T. Cribriform-morular variant of papillary thyroid carcinoma : clue to early detection of familial adenomatous polyposis-associated colon cancer. World J Surg. 2004;28:886-889.
  • [5] Levy R.A., Hui V.W., Sood R. Cribriform-morular variant of papillary thyroid carcinoma : an indication to screen for occult FAP. Fam Cancer. 2014;13:547-551.
  • [6] Pacini F, Castagna MG, Brilli L, Pentheroudakis G, on behalf of the ESMO Guidelines Working Group Author Notes. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2012 ; 23 : Issue suppl_7, vii110-vii119.
  • [7] Xing M., Alzahrani A.S., Carson K.A. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol. 2015;33:42-50.
  • [8] Yoo S.K., Lee S., Kim S.J. Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers. PLoS Genetics. 2016;12:e1006239. 8
  • [9] Cetta F., Montalto G., Gori M. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma : results from a European cooperative study. J Clin Endocrinol Metab. 2000;85:286-292.
  • [10] Ghorbanoghli Z, Bastiaansen BAJ, Langers AMJ, et al. Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis. J Med Genet 2018 ; 55 : 11-4.
  • [11] Balmaña J, Balaguer F, Cervantes A, Arnold D ; ESMO Guidelines Working Group. Familial risk-colorectal cancer : ESMO Clinical Practice Guidelines. Ann Oncol 2013 ; 24 (Suppl. 6 ): vi73-80.
  • [12] Stoffel E.M., Mangu P.B., Gruber S.B. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015;33:209-217.
  • [13] Syngal S., Brand R.E., Church J.M. ACG clinical guideline : Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223-262.